U-shaped microcavities made of PEG hydrogel ensure consistent, uniform organoid formation for reliable 3D culture results. InSphero Logo InSphero acquires DOPPL SA and Sun Bio’s Gri3D® platform, ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
Advanced 3D cell models recreate the complexity of human tissues, enabling researchers to examine tumor progression, probe neurological disorders, and assess therapeutic candidates. By capturing the ...
The Advanced Cell Engineering and 3D Models (ACE-3M) Core provides established services offered previously by AIM and C-BASS cores plus new expanded capabilities for tumor organoids grown in 3D ...
3D bio-printed liver model and high-content imaging for evaluating the toxicity effects of compounds
The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
New confocal fluorescence imaging minimizes photobleaching and phototoxicity effects, capturing clear images of live 3D culture Industry-leading throughput enables real-time analysis of up to six ...
15don MSN
Building breath, layer by layer: 3D printing with living lung cells in extreme environments
Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight and space travel protocols safer while driving new breakthroughs in ...
(MENAFN- EIN Presswire) EINPresswire/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire the DOPPL SA, a ...
InSphero acquires DOPPL SA and Sun Bioscience’s Gri3D® platform, expanding its unified 3D spheroid–organoid ecosystem for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback